Malignancy risk in patients with rheumatoid arthritis initiating biological or targeted synthetic disease-modifying antirheumatic drugs: a 5-year population-based cohort study.
Saved in:
| Title: | Malignancy risk in patients with rheumatoid arthritis initiating biological or targeted synthetic disease-modifying antirheumatic drugs: a 5-year population-based cohort study. |
|---|---|
| Authors: | Kao CM; Division of Allergy, Immunology, and Rheumatology, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.; Division of Translational Medicine, Department of Medical Research, Taichung Veterans General Hospital, Taichung, Taiwan.; Doctoral Program in Tissue Engineering and Regenerative Medicine, College of Medicine, National Chung Hsing University, Taichung, Taiwan.; Department of Post-Baccalaureate Medicine, College of Medicine, National Chung Hsing University, Taichung, Taiwan., Shih PC; Division of Allergy, Immunology, and Rheumatology, Department of Internal Medicine, Changhua Christian Hospital, Changhua, Taiwan.; Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan., Chen DY; Department of Post-Baccalaureate Medicine, College of Medicine, National Chung Hsing University, Taichung, Taiwan.; Institute of Biomedical Science, Rong Hsing Research Center for Translational Medicine and Big Data Center, National Chung Hsing University, Taichung, Taiwan.; Rheumatology and Immunology Center, China Medical University Hospital, Taichung, Taiwan.; School of Medicine, China Medical University, Taichung, Taiwan., Chen HH; Division of Allergy, Immunology, and Rheumatology, Department of Internal Medicine, Taichung Veterans General Hospital, No. 1650, Sec. 4, Taiwan Boulevard, Taichung 40705, Taiwan.; Department of Post-Baccalaureate Medicine, College of Medicine, National Chung Hsing University, Taichung, Taiwan.; Institute of Biomedical Science, Rong Hsing Research Center for Translational Medicine and Big Data Center, National Chung Hsing University, Taichung, Taiwan.; Department of Industrial Engineering and Enterprise Information, Tunghai University, Taichung, Taiwan.; School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.; Department of Digital Medicine, Taichung Veterans General Hospital, Taichung, Taiwan. |
| Source: | Therapeutic advances in musculoskeletal disease [Ther Adv Musculoskelet Dis] 2026 Feb 23; Vol. 18, pp. 1759720X261423830. Date of Electronic Publication: 2026 Feb 23 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Sage Country of Publication: England NLM ID: 101517322 Publication Model: eCollection Cited Medium: Print ISSN: 1759-720X (Print) Linking ISSN: 1759720X NLM ISO Abbreviation: Ther Adv Musculoskelet Dis Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
